Adacel Approval History
FDA Approved: Yes (First approved June 10, 2005)
Brand name: Adacel
Generic name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap)
Company: Aventis Pasteur Limited
Treatment for: Tetanus Prophylaxis, Diphtheria Prophylaxis, Pertussis Prophylaxis
Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap)) is indicated for active booster immunization for the prevention of tetanus, diphtheria and pertussis.
Development History and FDA Approval Process for Adacel
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.